1st Quarter - Report

ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) for EMD SERONO INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

- Issues involving the Federal, Food, Drug and Cosmetic Act (FFDCA), including reauthorization of the Prescription Drug User Fee Act (PDUFA VI) - Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (S. 771) - Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)

LobbyistCovered position, as disclosed
STEVEN E IRIZARRY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1245 (115th), S. 771 (115th), S. 469 (115th)

Health Issues HCR

- Legislation repealing and replacing the Affordable Care Act, including the American Health Care Act (H.R. 1628)

LobbyistCovered position, as disclosed
STEVEN E IRIZARRY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1628 (115th)

Medicare/Medicaid MMM

- Issues related to Medicare Part D

LobbyistCovered position, as disclosed
STEVEN E IRIZARRY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.